Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
Joany E KreijneR L GoetgebuerN S ErlerNanne K H De BoerA G SiebersG DijkstraF A van KemenadeFrank HoentjenB OldenburgA E van der MeulenC I J PonsioenM J PierikC J van der WoudeA C de Vriesnull nullPublished in: Alimentary pharmacology & therapeutics (2023)
Cumulative exposure to IM is associated with increased risk of CIN2+ in women with IBD. In addition to active counselling of IBD women to participate in cervical screening programs, further assessment of the benefit of intensified screening of women with IBD on long-term IM exposure is warranted.